Interferon gamma mediates the reduction of adipose tissue regulatory T cells in human obesity

David Bradley,Alan J Smith,Alecia Blaszczak,Dharti Shantaram,Stephen M Bergin,Anahita Jalilvand,Valerie Wright,Kathleen L Wyne,Revati S Dewal,Lisa A Baer,Katherine R Wright,Kristin I Stanford,Bradley Needleman,Stacy Brethauer,Sabrena Noria,David Renton,Joshua J Joseph,Amy Lovett-Racke,Joey Liu,Willa A Hsueh
DOI: https://doi.org/10.1038/s41467-022-33067-5
2022-09-24
Abstract:Decreased adipose tissue regulatory T cells contribute to insulin resistance in obese mice, however, little is known about the mechanisms regulating adipose tissue regulatory T cells numbers in humans. Here we obtain adipose tissue from obese and lean volunteers. Regulatory T cell abundance is lower in obese vs. lean visceral and subcutaneous adipose tissue and associates with reduced insulin sensitivity and altered adipocyte metabolic gene expression. Regulatory T cells numbers decline following high-fat diet induction in lean volunteers. We see alteration in major histocompatibility complex II pathway in adipocytes from obese patients and after high fat ingestion, which increases T helper 1 cell numbers and decreases regulatory T cell differentiation. We also observe increased expression of inhibitory co-receptors including programmed cell death protein 1 and OX40 in visceral adipose tissue regulatory T cells from patients with obesity. In human obesity, these global effects of interferon gamma to reduce regulatory T cells and diminish their function appear to instigate adipose inflammation and suppress adipocyte metabolism, leading to insulin resistance.
What problem does this paper attempt to address?